ma rc ia l zuc ke r ph d zi vd l l c
play

Ma rc ia L . Zuc ke r, Ph.D. ZI VD L L C 1 De finitio n o f - PowerPoint PPT Presentation

Ma rc ia L . Zuc ke r, Ph.D. ZI VD L L C 1 De finitio n o f Sta tistic s: T he sc ie nc e o f pro duc ing unre lia b le fa c ts fro m re lia b le fig ure s. E va n E sa r Be a b le to a na lyze sta tistic s, whic h c


  1. Ma rc ia L . Zuc ke r, Ph.D. ZI VD L L C 1

  2.  De finitio n o f Sta tistic s: T he sc ie nc e o f pro duc ing unre lia b le fa c ts fro m re lia b le fig ure s.  E va n E sa r  Be a b le to a na lyze sta tistic s, whic h c a n b e use d to suppo rt o r unde rc ut a lmo st a ny a rg ume nt.  Ma rilyn vo s Sa va nt 2

  3.  A ne w POCT is to b e imple me nte d › Multiple re plic a te s o f c o ntro ls run › Run side b y side pa tie nt sa mple s with c urre nt me tho d › Da ta is:  E nte re d into E P E va lua to r OR  E nte re d into Sta tisPro  Se nt to ma nufa c ture r › Re po rt re turne d with lo ts o f sta tistic s  Ma nufa c ture r re p e xpla ins it is a ll g o o d  Ho w do I kno w it is OK ? 3

  4.  Adva nc e fo r Administra to rs o f the L a b o ra to ry  We b ina r o n sta tistic s b y Da vid Pla ut  E xc e l T e mpla te s fo r:  L ine a rity  5 sa mple s; 2-4 re plic a te s e a c h  Re pro duc ib ility  20 va lue e va lua tio n 4 sa mple c o mpa riso n b e twe e n syste ms  Me tho d Va lida tio n  35 sa mple s  80 sa mple s   F re e do wnlo a da b le b o o k “Unde rsta nding L a b o ra to ry Sta tistic s”  http:/ / la b o ra to ry-ma na g e r.a d va nc e we b .c o m/ We b ina r/ E d ito ria l- We b ina rs/ Ma king -Se nse -o f-L a b o ra to ry-Sta tistic s.a sp x 4

  5.  Qua ntita tive Me tho ds › Sta tistic s we use a ssume a norma l distribution SD 5

  6.  Me a sure o f the va ria b ility o f the syste m › Ho w c lo se a re multiple re plic a te s?  Hig he r numb e r o f re plic a te s a llo ws b e tte r e stima te o f pre c isio n  Outlie rs a ffe c t sma ll numb e rs muc h mo re sig nific a ntly  Ca lc ula tio ns a ssume a No rma l Distrib utio n › F re q ue ntly untrue a ssumptio n, b ut use d a nywa y. 6

  7. 7

  8. 6 7 6 N=10 5 N=20 5 4 Frequency Frequency 4 3 3 2 2 1 1 0 0 3 3.25 3.5 3.75 4 4.25 3 3.25 3.5 3.75 4 4.25 4.5 4.75 Result Result 45 40 N=100 35 30 Frequency 25 20 15 10 5 0 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 8 Result

  9.  Me a n – c e ntra l te nde nc y o f the da ta › Pe a k o f the b e ll c urve (Ave ra g e use d in pra c tic e )  Me dia n › Va lue whe re 50% o f sa mple s a re lo we r & 50% hig he r  Sta nda rd de via tio n (SD) – me a sure o f va ria b ility › Width o f the b e ll c urve › Re la te s to diffe re nc e b e twe e n individua l re sults a nd the me a n  Sta nda rd e rro r (SE ) – me a sure o f SD o f the me a n › Ca lc ula te d fro m va ria nc e (SD 2 ) & N  95% Co nfide nc e inte rva l › E stima te o f “truth” fro m da ta c o lle c te d › 95% pro b a b ility tha t the “true ” va lue is within the inte rva l de fine d 9

  10. Statistic N=10 N=20 N=100 Me a n 3.90 4.17 4.22 95% CI me a n 3.65 – 4.14 4.00 – 4.35 4.14 – 4.27 SE 0.11 0.08 0.02 SD 0.34 0.38 0.24 8.7% 9.1% 5.7% Me d ia n 3.99 4.21 4.25 95% CI me d ia n 3.45 – 4.20 4.01 – 4.44 4.19 – 4.29 10

  11. 2.5 N=8 2 Frequency 1.5 1 0.5 0 3.85 3.9 3.95 4 4.05 4.1 4.15 4.2 4.25 Result 25 N=98 20 Frequency 15 10 5 0 3.8 3.9 4 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Result 11

  12. Statistic N=10 N=8 N=100 N=98 Me a n 3.90 4.04 4.22 4.24 95% CI me a n 3.65 – 4.14 3.92 – 4.16 4.14 – 4.27 4.20 – 4.28 SE 0.11 0.05 0.02 0.02 SD 0.34 0.14 0.24 0.20 8.7% 3.5% 5.7% 4.8% Me d ia n 3.99 4.05 4.25 4.25 95% CI me d ia n 3.45 – 4.20 3.86 – 4.23 4.19 – 4.29 4.20 – 4.30 12

  13.  Sta tistic s o fte n lo o k b e tte r a t hig he r me a n va lue s › If me a n is 0.1 a n SD o f 0.05 is 50% CV › If me a n is 100 a n SD o f 5.0 is 5% CV  E va lua te va lue s re po rte d in inse rts › Sho uld b e ne a r c linic a l de c isio n po ints › Re q uire d fo r ne we r pro duc ts › F o r o lde r pro duc ts e xpe c t to se e mo re va ria b ility in e nd-use r re sults 13

  14.  Co mpa riso n to “truth” › T ruth usua lly de fine d a s c urre nt syste m › T ruth a myth fo r ma ny a na lyte s  No ta b ly c o a g ula tio n, tro po nin I, o the r no n- sta nda rdize d a na lyte s  Ho w c lo se do e s POCT c o me to la b re sult › Co rre la tio n using pa tie nt sa mple s 14

  15. 15

  16. 1200 Re g re ssio n 1000 line 800 Da ta W NE po ints 600 ACT 400 Re g re ssio n y = 1.03x + 3.6 200 R = 0.965 e q ua tio n 0 0 200 400 600 800 1000 ACT OL D

  17.  Da ta po ints › E a c h split sa mple g e ne ra te s o ne po int › Ho rizo nta l (X) a xis is L a b (c urre nt syste m) › Ve rtic a l (Y) a xis is po int o f c a re (ne w) de vic e  Re g re ssio n line › Ma the ma tic a l pre dic tio n o f re la tio nship b e twe e n two de vic e s

  18.  Re g re ssio n e q ua tio n › 3 pa rts: Y = mX + b (y = 1.03x + 3.6)  Y = POC (ne w) re sult; X = la b (c urre nt) re sult  m = slo pe - pe rfe c t c o rre la tio n m = 1.0  b = inte rc e pt - pe rfe c t c o rre la tio n b = 0.0 › r va lue - c o rre la tio n c o e ffic ie nt  NOT 2 r  De sc rib e s ho w muc h o f the c ha ng e in Y va lue is due to the c ha ng e in the X va lue  r = 0.91 me a n 91% c o rre la tio n

  19. Glucose 150 140 130 120 110 POC 100 y = 1.08x + 5.53 90 80 R = 0.906 70 60 50 50 70 90 110 130 150 Lab  Ca nno t judg e › All va lue s c lo se to no rma l ra ng e › No thing a b o ve 150  E va lua te the a xe s whe n lo o king a t c o rre la tio n g ra phs

  20. 400 y = 1.01x - 9.86  Assa y ra ng e to 500, so 350 R = 0.980 300 spre a d se e ms OK 250 › Iso la te d va lue drive s 200 150 c o rre la tio n 100  Orig ina l da ta se t sho we d 50 0 o ut o f ra ng e va lue s 0 100 200 300 400 › T he se must b e e xc lude d 180 y = 0.94x - 1.90 160 b e fo re re g re ssio n run R = 0.937 140 120  Re vise d da ta ha s sa me 100 issue s a s prio r g luc o se 80 60 re sults 40 20 0 0 50 100 150 200 20

  21.  Da ta ne e d to spa n the c linic a lly impo rta nt ra ng e › Sing le e xtre me va lue s sho uld b e o mitte d › Out o f ra ng e va lue s must b e o mitte d 21

  22.  Diffe re nc e plo t › Bla nd Altma n a na lysis › Plo t e ithe r sta nda rd o r a ve ra g e o f two me tho ds a s X  Sta nda rd use d whe n c o nside re d “truth”  e .g ., POC e le c tro lyte s ve rsus la b  Ave ra g e use d whe n “truth” is unc e rta in  e .g ., ACT c o mpa riso ns › Plo t diffe re nc e b e twe e n two re sults a s Y 22

  23.  L o o k fo r b ia s › Co nsta nt o r va ria b le ? › Clinic a lly sig nific a nt? 6.0 6.0 5.0 5.0 4.0 Current INR - New INR 4.0 Current INR - New INR 3.0 3.0 2.0 2.0 1.0 1.0 0.0 0.0 0.0 2.0 4.0 6.0 8.0 10.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 -1.0 -1.0 -2.0 -2.0 -3.0 -3.0 -4.0 -4.0 -5.0 -5.0 -6.0 -6.0 Mean INR Mean INRs

  24.  Cha ng e o f c linic a l de c isio n limit c a n ma inta in c urre nt pra c tic e sta nda rds 900 800 y = 1.09x - 7.53 700 R = 0.915 T a rg e t T ime 600 c ha ng e fro m Ne w ACT 500 480 to 520 400 se c o nds 300 200 100 0 0 200 400 600 800 1000 Cur r e nt ACT 24

  25. LAB POC A >0.1 <0.1 >0.1 28 1 PPV 97% <0.1 2 9 NPV 82% Sensitivity Specificity Concordance 93% 90% 93% LAB POC B >0.1 <0.1 >0.1 18 0 PPV 100% <0.1 12 10 NPV 45% Sensitivity Specificity Concordance 60% 100% 70% 25

  26.  Se nsitivity › a b ility o f a n a ssa y to ide ntify pa tie nts with a spe c ific c o nditio n ( true po sitive s )  Spe c ific ity › a b ility o f a n a ssa y to ide ntify pa tie nts witho ut a spe c ific c o nditio n ( true ne g ative s )  Po sitive pre dic tive va lue › like liho o d tha t a pa tie nt with a po sitive re sult (o r a b o ve the c ut-o ff) truly ha s the c o nditio n  Ne g a tive pre dic tive va lue › like liho o d tha t a pa tie nt with a ne g a tive re sult (o r b e lo w the c ut-o ff) is truly no rma l 26

  27. “T rue ” Re sult Positive Ne gative T rue po sitive F a lse po sitive Po sitive pre d ic tive Positive Ne w (T P) (F P) va lue (PPV) Syste m Ne gative F a lse T rue ne g a tive Ne g a tive pre d ic tive Re sult ne g a tive (F N) (T N) va lue (NPV) Se nsitivity Spe c ific ity Co nc o rd a nc e  27

  28.  Qua lita tive te sts a lwa ys inc lude se nsitivity a nd spe c ific ity c la ims › Olde r pro duc ts ha ve limite d c linic a l da ta  Only spike d sa mple s e va lua te d  Only fro ze n c linic a l sa mple s e va lua te d  T o o fe w sa mple s e va lua te d › Ne we r pro duc ts will inc lude c o nfide nc e inte rva ls  Do no t wa nt te st whe re CI spa ns 50% (c o in to ss) 28

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend